Next Post

New COVID-19 nasal spray outperforms current antibody treatments in mice

CryoEM graphic of the novel coronavirus’ spike protein. Credit rating: Northwestern College/Washington University/College of Washington A new protein-dependent antiviral nasal spray created by researchers at Northwestern College, University of Washington and Washington College at St. Louis is remaining superior toward Phase I human scientific trials to treat COVID-19. Made computationally […]